HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Balram Bhargava Selected Research

BBV152 COVID-19 vaccine

12/2021Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
10/2021Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine.
10/2021Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.
1/2021Antibody responses to the BBV152 vaccine in individuals previously infected with SARS-CoV-2: A pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Balram Bhargava Research Topics

Disease

11COVID-19
12/2024 - 05/2020
7Thrombosis (Thrombus)
01/2018 - 01/2004
6Hypertension (High Blood Pressure)
07/2023 - 08/2015
5Infections
12/2023 - 05/2020
5Coronary Artery Disease (Coronary Atherosclerosis)
10/2021 - 09/2004
4Ischemia
01/2023 - 01/2019
4Hyperplasia
05/2008 - 05/2002
3Coronary Disease (Coronary Heart Disease)
01/2023 - 01/2020
3Inflammation (Inflammations)
07/2017 - 05/2006
3Mitral Valve Stenosis (Mitral Stenosis)
07/2017 - 12/2009
2ST Elevation Myocardial Infarction
01/2022 - 01/2022
2Pneumonia (Pneumonitis)
01/2021 - 01/2021
2Dyspnea (Shortness of Breath)
01/2021 - 07/2014
2Heart Failure
01/2019 - 01/2011
2Cardiomyopathies (Cardiomyopathy)
10/2016 - 12/2006
2Eisenmenger Complex (Eisenmenger's Syndrome)
07/2014 - 05/2011
2Acute Coronary Syndrome
01/2014 - 01/2011
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
11/2008 - 12/2006
1Arteritis
02/2024
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Body Weight (Weight, Body)
01/2022
1Chronic Disease (Chronic Diseases)
12/2021
1Anaphylaxis (Anaphylactic Shock)
12/2021
1Chronic Renal Insufficiency
10/2021
1Amyloidosis
10/2021
1Immunoglobulin Light-chain Amyloidosis
10/2021
1Amyloid Plaque
10/2021
1Aortic Valve Stenosis (Aortic Stenosis)
10/2021
1Severe Acute Respiratory Syndrome
02/2021
1Ulcer
01/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1Reinfection
01/2021
1Pain (Aches)
01/2021
1Chronic Limb-Threatening Ischemia
01/2021
1Virus Diseases (Viral Diseases)
02/2020
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2019
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2019
1Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
06/2018
1Sudden Death
06/2018
1Cardiac Arrhythmias (Arrythmia)
06/2018
1Infarction (Infarctions)
01/2018
1Neoplasms (Cancer)
11/2017
1Nervous System Diseases (Neurological Disorders)
11/2017
1Dysbiosis
11/2017
1Atrial Fibrillation
07/2017
1Necrosis
10/2016

Drug/Important Bio-Agent (IBA)

8VaccinesIBA
12/2024 - 01/2021
4BBV152 COVID-19 vaccineIBA
12/2021 - 01/2021
4Proteins (Proteins, Gene)FDA Link
10/2021 - 05/2002
3COVID-19 VaccinesIBA
12/2021 - 10/2021
3FibrinIBA
01/2018 - 05/2006
3Brain Natriuretic Peptide (Natrecor)FDA Link
10/2016 - 10/2010
2AntigensIBA
10/2023 - 01/2021
2Antihypertensive Agents (Antihypertensives)IBA
01/2023 - 01/2021
2Oxygen (Dioxygen)IBA
01/2021 - 01/2021
2Interleukin-6 (Interleukin 6)IBA
07/2017 - 10/2016
2C-Reactive ProteinIBA
07/2017 - 10/2016
2Vasodilator Agents (Vasodilators)IBA
07/2014 - 11/2005
2Sildenafil Citrate (Viagra)FDA Link
07/2014 - 11/2008
2PolymersIBA
05/2008 - 05/2006
1ChAdOx1 nCoV-19IBA
12/2024
1GoldIBA
12/2023
1Glucose (Dextrose)FDA LinkGeneric
05/2023
1SaltsIBA
01/2023
1Viral RNAIBA
01/2022
1Toll-Like Receptor 7IBA
12/2021
1aluminum sulfate (alum)IBA
12/2021
1Insulin (Novolin)FDA Link
10/2021
1diphosphoric acid (pyrophosphoric acid)IBA
10/2021
1Prealbumin (Transthyretin)IBA
10/2021
1Viral AntigensIBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1salicylhydroxamic acid (SHAM)IBA
01/2021
1Pain-FreeIBA
01/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
05/2020
1Antimalarials (Antimalarial Agents)IBA
05/2020
1AerosolsIBA
05/2020
1Nucleic AcidsIBA
02/2020
1Antiviral Agents (Antivirals)IBA
02/2020
1Purinergic Receptors (Receptors, Purine)IBA
01/2019
1Ligand-Gated Ion ChannelsIBA
01/2019
1trimethyloxamine (trimethylamine N-oxide)IBA
11/2017
1Glutathione (Reduced Glutathione)IBA
10/2016
1CytokinesIBA
10/2016
1Thiobarbituric Acid Reactive SubstancesIBA
10/2016
1Superoxide DismutaseIBA
10/2016

Therapy/Procedure

10Therapeutics
01/2023 - 01/2004
6Stents
01/2014 - 01/2004
2Percutaneous Coronary Intervention
01/2022 - 05/2002
2Thrombolytic Therapy
01/2022 - 01/2015
2Drug-Eluting Stents
12/2012 - 05/2008
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2024
1Retention in Care
07/2023
1Conservative Treatment
01/2023
1Continuity of Patient Care
01/2021
1Artificial Respiration (Mechanical Ventilation)
01/2021
1Surgical Amputation (Amputations)
01/2021
1Personal Protective Equipment
05/2020
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
06/2018